[Regression of an osteolytic lesion in a patient with multiple myeloma treated with clodronate after a successful therapy with bortezomib-based regimen].

MLA

Szturz, P., et al. “[Regression of an Osteolytic Lesion in a Patient with Multiple Myeloma Treated with Clodronate after a Successful Therapy with Bortezomib-Based Regimen].” Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti, vol. 24, no. 3, 2011, pp. 216–20. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=21717791&authtype=sso&custid=ns315887.

APA

Szturz, P., Jakubcová, R., Adam, Z., Klincová, M., Krejcí, M., Pour, L., Zahradová, L., Hájek, R., & Mayer, J. (2011). [Regression of an osteolytic lesion in a patient with multiple myeloma treated with clodronate after a successful therapy with bortezomib-based regimen]. Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti, 24(3), 216–220.

Chicago

Szturz, P, R Jakubcová, Z Adam, M Klincová, M Krejcí, L Pour, L Zahradová, R Hájek, and J Mayer. 2011. “[Regression of an Osteolytic Lesion in a Patient with Multiple Myeloma Treated with Clodronate after a Successful Therapy with Bortezomib-Based Regimen].” Klinicka Onkologie : Casopis Ceske a Slovenske Onkologicke Spolecnosti 24 (3): 216–20. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=cmedm&AN=21717791&authtype=sso&custid=ns315887.